Skip to main content
Erschienen in: BMC Medical Imaging 1/2020

Open Access 01.12.2020 | Research article

Myofibroma/myofibromatosis: MDCT and MR imaging findings in 24 patients with radiological-pathological correlation

verfasst von: Kun-ming Yi, Kang Chen, Qiang Ma, Lu Wang, Ran Li, Yi Wang

Erschienen in: BMC Medical Imaging | Ausgabe 1/2020

Abstract

Background

The aim of this study was to characterize the radiological features of myofibroma on multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) and correlate the imaging findings with pathologic features.

Methods

The radiological findings of 24 patients with 29 myofibromas were retrospectively reviewed. All images were evaluated with emphasis on density, signal intensity, hypointense area, and enhancement, correlating these with pathologic findings.

Results

On plain MDCT scan, 4(26.7%) tumors were homogeneous isodensity, 4(26.7%) tumors were heterogeneous hyperdensity, and 7(46.7%) tumors were heterogeneous hypodensity. On contrast-enhanced MDCT scan, all tumors (9/9) showed heterogeneous enhancement with moderate in 3(33.3%) and marked in 6(66.7%) tumors, and their enhancements were higher compared to adjacent skeletal muscle (P = 0.0001). On MRI, heterogeneous slight hyperintensity, homogeneous slight hyperintensity, and heterogeneous hypointensity on T1-weighted imaging (T1WI) were observed in 14(82.3%), 1(5.9%) and 2(11.8%) tumors, respectively. On T2-weighted imaging (T2WI) and fat-suppressed (FS) T2WI, all tumors demonstrated heterogeneous hyperintensity. All tumors showed heterogeneous marked enhancement on FS contrast-enhanced T1WI. On T1WI, T2WI, FS T2WI, and FS contrast-enhanced T1WI, irregular strip or/and patchy hypointensities were found in 16(94.1%), 12(100%), 17(100%) and 17(100%) tumors, respectively, and pseudocapsule was seen in 5(29.4%) tumors. The hypointensities and pseudocapsule on MRI were exactly corresponding to pathological interlacing collagen fibers and fibrosis. The age of the recurrent group was lower than that of the non-recurrent group (P = 0.001) and the tumors without pseudocapsule were more likely to recur than those with pseudocapsule (P = 0.034).

Conclusion

Myofibromas are characterized by heterogeneous density or signal intensity, with moderate or marked enhancement. The hypointensities and pseudocapsule on MRI may be helpful in diagnosis, and the absence of pseudocapsule and younger age may be risk factors for tumor recurrence.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
MDCT
Multidetector computed tomography
MRI
Magnetic resonance imaging
T1WI
T1-weighted imaging
T2WI
T2-weighted imaging
FS
fat-suppressed
HU
Hounsfield units
IQR
Interquartile range
TR
Repetition time
TE
Echo time

Background

Myofibroma/myofibromatosis is an uncommon disorder of fibroblastic/myofibroblastic proliferation with perivascular myoid differentiation and is one of the most common benign fibrous tumors in infancy and childhood [13]. Currently, in the WHO classification of tumors of soft tissue and bone, myofibroma/myofibromatosis was classified as part of pericytic/perivascular tumors, the term myofibroma was used to denote solitary lesions and the term myofibromatosis to designate those multicentric [4]. The genetic etiology of the disorder remains uncertain, both autosomal dominant and autosomal recessive inheritance have been reported, the mutation in PDGFRB, NOTCH3 and PTPRG are associated with autosomal dominant multicentric myofibromatosis [5, 6].
Clinically, myofibromas frequently present as slowly growing, asymptomatic single mass or diffuse multiple nodules in the dermis and subcutaneous tissues of the head and neck region, although they can also affect the trunk, extremities, skeletal muscles, bone or internal organs [2, 7]. Most patients occur in neonates or infants during the first decade of life, however, they have also been reported in adults [7, 8]. There is a slight male predominance, with a reported male/female ratio of 1.3–2.4:1 [2, 79]. The greatest diameter of myofibromas ranged from 0.3 to 17.8 cm [7, 8, 1012]. Additionally, three clinical types of myofibroma are recognized: (1) solitary type (a single lesion in the skin, subcutaneous tissue, muscle, bone or viscus), (2) multicentric type (multicentric lesions limited to skin, subcutaneous tissues, muscles, and bones, without visceral involvement), (3) generalized type (multicentric lesions with visceral involvement) [2, 13]. In these types of myofibroma, the solitary form is the most common type, multicentric type with nonvisceral lesions accounts for the majority of familial-related myofibromatosis [2]. Spontaneous involution is common, the solitary type and multicentric type with single (or limited) visceral lesion have a better prognosis than the multicentric type with multiple visceral lesions [2, 14].
Radiological examinations can be helpful in assessing the extent of the myofibroma/myofibromatosis and its progression and prognosis. However, the plain radiography, computed tomography and magnetic resonance imaging (MRI) findings of myofibroma are mostly case reports and small series [11, 12, 1530], and some imaging findings in our study have rarely or never been reported. Our study aimed to describe the multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) findings of the myofibroma and to correlate them with pathologic features, in order to improve the diagnostic accuracy of preoperative radiological examinations.

Methods

Clinical data

Our institutional ethics committee approved this study and waived the need for individual consent due to its retrospective nature. Between January 2011 and December 2018, all patients with myofibroma/myofibromatosis were identified at our institutions. Finally, a series of 24 patients with preoperative radiological examinations were enrolled and their first preoperative radiological images were reviewed. Of these 24 patients, MDCT and MRI scans were obtained in 12 and 15 patients, respectively, and 3 of them underwent both MDCT and MRI scans. Clinical characteristics including age, sex, anatomic locations, and types of the tumor, clinical symptoms and signs, surgical and pathological findings, treatment, and outcomes, were obtained through a review of medical records.
The diagnosis was confirmed by review of pathology slides of all cases. All specimens were fixed in 4% buffered formalin, routinely processed, and then embedded in paraffin; 4-μm-thick sections were prepared and stained with hematoxylin and eosin (HE). Immunostaining was performed in all the patients for smooth muscle actin (SMA), desmin, S-100 protein, CD34, Calponin, and Ki-67.

MDCT protocols

MDCT was performed in 12 patients by using either of the following medical imaging equipments: the 64–MDCT LightSpeed scanner (GE Healthcare, Milwaukee, WI, USA) and the 16–MDCT Emition scanner (Siemens, Erlangen, Germany). For contrast-enhanced MDCT scans, the non-ionic contrast agent (Ultravist, Bayer Schering Pharma; Omnipaque, GE Healthcare) + 30 mL normal saline was intravenously injected through the antecubital vein at a rate of 2.5–4.5 mL/s. Contrast agent volume was administered at 2 mL/kg body weight, and the upper dose limit was 120 mL for every patient. Of these 12 patients, triple-phase contrast-enhanced MDCT scans were performed for 3 patients with 4 lesions (the locations included the penis in 1 patient with 2 lesions, and the other 2 lesions were located in the psoas and abdominal wall, respectively), images of the arterial, venous and delayed phases were acquired at 24–30, 45–60 and 120 s, respectively, after contrast agent injection. Dual-phase contrast-enhanced MDCT images were obtained for 5 patients with 5 lesions (the lesions were located at the neck in 1 patient and maxillofacial region in 4 patients), with arterial and venous phases at 20–25 and 50–55 s, respectively. Scan parameters were as follows: tube voltage 100–120 kV and tube current 100–320 mA, 3 or 5-mm-thick slice reconstructions, matrix 512 × 512, field of view 120–500 mm. All MDCT studies performed axial and coronal reformations, the sagittal reformations were performed selectively.
Both soft-tissue and bone windows were reviewed. Both unenhanced and enhanced MDCT scans were performed for 8 patients with 9 tumors, only enhanced was performed for 1 patient with 1 tumor, and unenhanced MDCT scans were obtained in 3 patients with 5 tumors. Attenuation at the soft-tissue window was measured on the workstation in the MDCT images before and after contrast administration in the same section, areas of cystic degeneration, calcification and necrosis were avoided. Mean density values were recorded in Hounsfield units (HU).

MRI protocols

Fifteen patients underwent MRI examination. Among them, 12 patients were performed with a 1.5-T system (Magnetom Aera, Siemens, Erlangen, Germany; Avanto, Siemens, Erlangen, Germany) and 3 patients with a 3.0-T system (Magnetom Verio, Siemens, Erlangen, Germany; Magnetom Trio TIM, Siemens, Erlangen, Germany; Magnetom Spectra, Siemens, Erlangen, Germany). In addition, the section thickness was 3 mm, the intersection gap was 1 mm, the field of view was 120–380 mm. In all patients, spin-echo (SE) T1-weighted imaging (T1WI) (repetition time/echo time [TR/TE], 450–750 ms/9–12 ms), fat-suppressed (FS) fast SE T2-weighted imaging (T2WI) (TR/TE, 3000–9000 ms/35–86 ms), and FS gadolinium-enhanced SE T1WI (TR/TE, 530–750 ms /9–12 ms) were obtained. Gadolinium-enhanced SE T1WI (TR/TE, 450–752 ms /9–10 ms) or T2WI (TR/TE, 3600–4350 ms /36–80 ms) was obtained in some cases. Axial, coronal, or sagittal images were performed with the above sequences. Contrast-enhanced SE T1WI or/and FS contrast-enhanced SE T1WI were obtained after the intravenous injection of a standard dose of 0.1 mmol/kg body weight of gadopentetate dimeglumine (Magnevist; Bayer Healthcare). Both plain radiography and MRI scans were obtained in 4 patients.

Image viewing and evaluation

Two experienced radiologists (K.Y., Y.W., with 9 and 24 years of experience in diagnostic imaging of the musculoskeletal system, respectively) performed the imaging analysis independently on picture archiving and communication system (PACS). In cases of discrepancies in the interpretations of the two radiologists, a consensus was reached. The radiological findings were evaluated for the following characteristics: (1) number (solitary or multifocal); (2) locations; (3) shape (round, oval, or lobular); (4) margins (well-defined or poorly defined); (5) size (maximal diameter); (6) density, signal intensity and enhancement patterns on MDCT/MRI scans (homogeneous or heterogenous, compared with the adjacent skeletal muscle); (7) hypointense area on MRI scans (defined as irregular strip or/and patchy hypointensities within the tumor on all MRI sequences); (8) pseudocapsule (defined as a complete or incomplete low signal rim at the periphery of the lesion on T1WI, T2WI, and FS T2WI); (9) the degrees of enhancement on MDCT scans included three types according to the increase in CT values: mild (10 to < 30 HU), moderate (30–50 HU), and marked (> 50 HU), and tumor enhancements were also compared with that of the adjacent skeletal muscle; (10) calcifications, fat, haemorrhage, necrosis, and cysts.

Statistical analysis

We stratified the patients with follow-up data into the recurrence group and non-recurrent group. Statistical analyses were performed with software (SPSS, version 20; SPSS, Chicago, IL, United States). An independent sample t-test was used to compare the differences between the enhancement values of tumors and adjacent skeletal muscles on MDCT and assess the difference between the age of the recurrence group and the non-recurrent group. The Mann-Whitney test was used to compare the differences in the maximum diameter of the tumors between the two groups. The difference of tumor recurrence between tumors with and without pseudocapsule was compared using Fisher exact test. The difference A P value of less than 0.05 was considered to indicate a significant difference.

Results

Clinical findings

The clinical characteristics are summarized in Table 1. In total, 24 patients (mean age, 32.3 ± 16.5 years; range, 8–64 years) with 29 tumors were identified in our study, including 7 men and 17 women. Of all patients, extremities (15, 51.7%) were the most common sites, followed by the head (6, 20.7%), trunk (6, 20.7%), and neck (2, 6.9%). Twenty-one patients (87.5%) presented solitary lesion and 3 patients (12.5%) showed multicentric involvement. In 2 patients, each of them had 3 lesions, one patient showed the lesions located in the bilateral hips and the right thigh (case 5) and another patient located in right thigh (case 21). Two subcutaneous tumors were found at the penis (case 11) in one patient. The main symptoms of the tumor mainly included painless swelling, enlarging mass, nodule, local pain, and limp.
Table 1
Clinical characteristics of 24 patients with myofibroma
Case
Location
Duration of symptoms before admission (M)
Type of myofibroma
Treatment
Follow-up
1
Hip
12
Solitary
Excision+ radiotherapy+ chemotherapy
Recurrence
2
Foot
6
Solitary
Excision
Recurrence
3
Hip
7
Solitary
Excision
Recurrence
4
Calf
2
Solitary
Excision
No recurrence
5
Right hip
Right thigh
Left hip
180
Multifocal
Excision
Excision
Excision
No recurrence
No recurrence
No recurrence
6
Upper arm
36
Solitary
Excision
Recurrence
7
Neck
36
Solitary
Biopsy
Lost to follow-up
8
Foot
9
Solitary
Excision
No recurrence
9
Maxillary sinus
5
Solitary
Excision
No recurrence
10
Calf
48
Solitary
Excision
Recurrence
11
Penis
Penis
6
Multifocal
Excision
Excision
No recurrence
No recurrence
12
Upper arm
68
Solitary
Excision
Recurrence
13
Rectus abdominis
3
Solitary
Excision
No recurrence
14
Pre-auricular
3
Solitary
Excision
No recurrence
15
Thigh
20
Solitary
Excision
Recurrence
16
Psoas
6
Solitary
Biopsy
Lost to follow-up
17
Iliac fossa
2
Solitary
Partial excision
Lost to follow-up
18
Maxillofacial
10
Solitary
Excision
No recurrence
19
Mandible
0.5
Solitary
Excision
No recurrence
20
Neck
1
Solitary
Excision
No recurrence
21
Right thigh
Right thigh
Right thigh
72
Multifocal
Excision
Excision
Excision
No recurrence
No recurrence
No recurrence
22
Pre-auricular
12
Solitary
Excision
No recurrence
23
Nasal vestibule
6
Solitary
Excision
No recurrence
24
Lumbar back
24
Solitary
Excision
No recurrence

MDCT findings

The MDCT features of 15 myofibromas in 12 patients are summarized in Table 2. In the 15 tumors, 4 (26.7%) were round or round-like masses with well demarcated, the remaining 11 (73.3%) tumors were lobulated masses with ill-defined margins. Their maximal diameter ranged from 0.9 to 28.5 cm (median 5.3, interquartile range [IQR] 2.4–14.4). In all tumors, 3(20%) involved both subcutaneous and adjacent tissues, including skeletal muscle (2, 13.3%) and parotid gland (1, 6.7%). One (6.7%) out of the 15 tumors occurred in left maxillary sinus with adjacent bone erosion, others involved subcutaneous tissue (4, 26.7%), skeletal muscle (5, 33.3%), parapharyngeal space (1, 6.7%), and mandible (1, 6.7%) (Fig. 1), respectively. Of the 15 tumors evaluated by MDCT, 4(26.7%) were homogeneous isodensity relative to the adjacent skeletal muscle, 4(26.7%) showed heterogeneous hyperdensity and 7(46.7%) appeared as heterogeneous hypodensity on the unenhanced MDCT images. 3(20%) out of the 15 tumors showed multiple irregular nodular calcifications at the bilateral buttocks and the right thigh in the same patient (case 5), and 5(33.3%) exhibited necrosis within these tumors.
Table 2
Radiological findings in the 24 patients with myofibroma
Radiological findings
No. (%) of lesions/median (IQR)
MDCT (n = 15)
MRI (n = 17)
Locations
 Head
4 (26.7%)
2 (11.8%)
 Neck
1 (6.7%)
1 (5.9%)
 Extremities
6 (40%)
12 (70.6%)
 Trunk
4 (26.7%)
2 (11.8%)
Density (n = 15)
 Isodensity; homogeneous
4 (26.7%)
 
 Iso-and high- density; heterogeneous
4 (26.7%)
 
 Iso-and low- density; heterogeneous
7 (46.7%)
 
 Necrosis
5 (33.3%)
 
 Calcifications
3 (20%)
 
Enhancement on MDCT (n = 9)
 Mild
0
 
 Moderate
3 (33.3%)
 
 Marked
6 (66.7%)
 
T1WI (n = 17)
 Homogeneous hypointensity
 
1 (5.9%)
 Heterogeneous hyperintensity
 
14 (82.3%)
 Heterogeneous hypointensity
 
2 (11.8%)
T2WI (n = 12)
 Homogeneous hyperintensity
 
0
 Heterogeneous hyperintensity
 
12 (100%)
FS T2WI (n = 17)
 Homogeneous hyperintensity
 
0
 Heterogeneous hyperintensity
 
17 (100%)
FS enhanced T1WI (n = 17)
 Homogeneous enhancement
 
0
 Heterogeneous enhancement
 
17 (100%)
Size
 Maximal diameter [cm; median (IQR)]*
5.3 (2.4–14.4)
4.5 (2.9–12.7)
*Unless otherwise noted, data are presented as number (%). MDCT, multidetector computed tomography; MRI, magnetic resonance imaging; T1WI, T1-weighted imaging; T2WI, T2-weighted imaging; FS, fat-suppressed; IQR, interquartile range
Attenuation data could be measured for 14 tumors with unenhanced scans and 9 of them with enhanced scans. In our series, the mean attenuation was 42.2 ± 10.8 HU (n = 14) on non-enhanced images, 96.8 ± 42.4 HU (n = 9) on the arterial phase images, 111.2 ± 39.5 HU (n = 9) on the venous phase images, and 122 ± 44.8 HU (n = 4) on the delayed phase images. The mean maximum enhancement value of the tumors was 78.9 ± 34.8 HU, and all actual enhancement were significantly higher than that of the adjacent skeletal muscle (11.7 ± 3.1 HU) (P = 0.0001). Tumor enhancements were moderate in 3(33.3%) and marked in 6(66.7%) (Fig. 1). All these 9 tumors (9/9) showed heterogeneous enhancement, 7(77.8%) of them presented progressive enhancement, and 2(22.2%) showed decreased enhancement in the latest phase (i.e. venous or delayed) of the enhanced scans.

MRI findings

The MRI features of 17 myofibromas in 15 patients are given in Table 2. In 17 tumors evaluated by MRI, 1 (5.8%) present as a round-like and well-defined nodule, all the other 16 (94.1%) tumors were lobulated masses with ill-defined margins. Their maximal diameter ranged from 1.5 to 28.5 cm (median 4.5, IQR 2.9–12.7). Among the 17 tumors, 4(23.5%) showed a combination of subcutaneous tissue and adjacent skeletal muscle invasion, and 2 of them showed bone destruction of phalanx on MRI and plain radiography; 1(5.9%) involved subcutaneous tissue and adjacent parotid gland; 11(33.3%) occurred in the skeletal muscle (Figs. 2 and 3) and 1(5.9%) located in the iliac fossa. Four (23.5%) out of the 17 tumors grew around the tendon (Fig. 3).
On T1WI, 14 (82.3%) tumors showed as heterogeneous slight hyperintensity, 1(5.9%) tumor showed homogeneous slight hyperintensity, and 2(11.8%) tumors showed heterogeneous hypointensity relative to the adjacent skeletal muscle. On T2WI, all 12(100%) tumors showed heterogeneous hyperintensity relative to the adjacent skeletal muscle, but relatively lower signal relative to the fat. On FS T2WI, all 17(100%) tumors showed heterogeneous hyperintensity. On T1WI, T2WI, and FS T2WI, there were 16(94.1%), 12(100%), and 17(100%) tumors with irregular strip or/and patchy hypointensities (Figs. 2 and 3) inside them, respectively, and pseudocapsule was found in 5(29.4%) tumors (Fig. 3). On FS contrast-enhanced T1WI, all 17(100%) tumors showed marked enhancement, but with irregular strip or/and patchy hypointensities within these tumors.

Pathological and immunohistochemical findings and accuracy of radiological diagnosis

Histopathologic specimens were obtained from all patients, including 27 specimens from the final surgery and 2 from the biopsy. Histological features of these tumors were as follows: (1) interlacing bundles of spindle-shaped cells with a large number of collagen fibers were found in all 29 tumors, the tumor cells were large and presented tapered nuclei with elongated and eosinophilic cytoplasm; (2) spindle-shaped cells were polygonal or round to spindle in shape with hyperchromatic nuclei, scant eosinophilic cytoplasm in some tumor regions; (3) haemangiopericytoma-like vascular pattern could be identified in 20 (69.0%) tumors; (4) sometimes, necrosis, calcification, and hyalinization (Fig. 2) can be identified; (5) mitoses and nuclear pleomorphism were rare. (6) a pseudocapsule consisting of peripheral collagen fibers was found in 5 (17.2%) tumors (Fig. 3), which corresponds to the low signal pseudocapsule on MRI. The immunohistochemical findings as follows: 24 (82.8%) out of 29 tumors were positive for SMA, 2/29 (6.9%) for desmin, 1/29 (3.4%) for S− 100 protein, 6/29 (20.7%) for CD34, 29/29 (100%) for Calponin, and 4/29 (13.8%) for Ki-67. Preoperative imaging data of all patients were diagnosed as various benign, malignant tumors or inflammation, without a definitive qualitative diagnosis.

Treatment outcomes and follow-up

Of the total 24 patients, 21 patients with 26 myofibromas were treated by complete excision and 1 of them (case 1) also received radiotherapy and chemotherapy, 1 patient underwent partial excision, and only tissue biopsy was performed in 2 patients. Twenty-one patients were followed up postoperatively for periods ranging from 6 months to 4 years (12.4 ± 6.8 months), 14 (58.3%) of them did not exhibit recurrence and no new lesion developed, but 7 (29.2%) were found to have local tumor recurrence and underwent reoperation. The remaining 3 patients were lost to follow-up. The age of the recurrent group (15.3 ± 7.0 years) was lower than that of the non-recurrent group (38.9 ± 14.3 years) (P = 0.001). There was no significant difference in the maximum diameter of the tumor between the recurrent group (median 5.6 cm, IQR 4.0–13.7) and the non-recurrent group (median 4.7 cm, IQR 2.6–13.5) (P = 0.572). The soft-tissue tumors without pseudocapsule (n = 11) on MRI were more likely to recur than those with pseudocapsule (n = 5) (P = 0.034).

Discussion

In this report, we described the radiological findings of the largest series of myofibromas of soft tissue and skeletal lesions to date. Myofibromas usually exhibited heterogeneous density or signal intensity, with progressive moderate or marked enhancement. On MRI, most tumors had irregular strip or/and patchy hypointensities on all MRI sequences, and 5 of them showed a pseudocapsule at the periphery of the lesion and 4 tumors grew around the tendon.
Myofibromas could occur at any bone, the cranio-orbito-facial bones were most often involved with a solitary lesion, while, the other bone lesions were frequently observed with the multicentric type (17–77%) [2, 7, 1518]. On plain radiography and CT, most skeletal lesions demonstrated well-defined, expansile, osteolytic, with or without a partial or poorly developed sclerotic rim which more commonly observed when the lesions start to heal [14, 18, 19]. Occasionally, periosteal reaction, cortical expansion, necrosis, and calcifications may be observed [15, 17]. Most intraosseous lesions of the mandible were unilocular radiolucency [20]. In our series, a mandible lesion simultaneously showed a partial sclerotic rim, periosteal reaction, and resorption of the external cortical bone, with marked enhancement. Vertebral body collapse was considered as another characteristic imaging findings of myofibromas [15, 21].
Nearly half of solitary myofibromas occurred in the deeper soft tissues of the aponeuroses, fascia, and skeletal muscle [2]. Soft-tissue lesions may be well-margin, or infiltrative and ill-defined on MRI or MDCT, and showed more invasive than bone lesions, and the erosion of adjacent bone could also be observed [12, 14]. In our study, we also found that 11 (40.7%) soft-tissue lesions simultaneously involved two or more tissues on MDCT or MRI, and 3 of them showed destruction of adjacent bone and 2 showed involvement parotid gland. Naffaa et al. [12] considered that the variable tumor margins could not predict microscopic invasion or cellular atypia. However, in our cohort, we found that a large number of tumor cells invade adjacent muscles at the edge of the soft-tissue lesions on pathology, which demonstrated lobulated mass with an infiltrative and ill-defined margin on MRI or MDCT. Our results indicated that the infiltrative tumor margins can predict microscopic invasion. Furthermore, we also found that the tumors without pseudocapsule were more likely to recur than those with pseudocapsule, and the age of the recurrent group was lower than that of the non-recurrent group. We suggested the absence of pseudocapsule and the younger age may be risk factors for tumor recurrence.
The density of the myofibromas of soft tissue was variable due to necrosis or calcification. Most soft-tissue lesions appeared with attenuation that is similar to or slightly higher than that of skeletal muscle on MDCT in our series and previous literature. However, some myofibromas presented with low density relative to the adjacent skeletal muscle on MDCT [12, 14, 19, 23], which was also observed in seven (7/15) of our cases. Necrosis or calcification could be seen in some cases. On MDCT, there were relatively few reports of the enhancement feature of soft-tissue myofibroma, most of them were ring-like or peripheral enhancement [12, 19, 23]. Naffaa et al. [12] described two soft-tissue lesions showed mild enhancement and all of them were slightly low or iso-density relative to the adjacent skeletal muscle on enhanced MDCT. In our study, we reported the largest number of cases of myofibromas with MDCT enhancement, and the enhancement value of the tumor was also quantitatively analyzed for the first time. Most of our cases presented heterogeneous moderate to the marked enhancement and progressive enhancement, and their actual enhancements were all higher than that of the adjacent skeletal muscle, and ring-like enhancement was rare. The reason for this difference may be that the vast majority of our cases were adults rather than infants and young children. Our study also did not observe a significant histological difference between lesions with moderate and marked enhancements.
As far as we know, the MRI signal characteristics of the myofibromas of soft tissue were also variable. Myofibromas were generally demonstrated as iso/hypointensity relative to the adjacent skeletal muscle on T1WI and hyperintensity on T2WI, and some cases showed a very high or low signal central region on T2WI due to necrosis, cystic, or mature myofibroblasts, or calcification [12, 14, 2225]. However, unlike previous studies, in our series, most (82.3%) of lesions showed a slight hyperintensity on T1WI and 12 (100%) lesions demonstrated as a heterogeneous high signal but lower than fat on T2WI. There are several possible reasons to explain why some myofibromas can present slightly higher signal relative to the skeletal muscle on T1WI. First, the cell density of the myofibroma may be higher than that of the adjacent normal skeletal muscle. Second, the T1 relaxation value of the tumor cells may be lower than that of the skeletal muscle. Third, in our series, the calcification, necrosis, and cystic degeneration are rare, these can cause a decrease of the signal on T1WI, and a large amount of collagenization and fibrosis are also the important reasons for the low signal on MRI. In addition, we first described that 5 tumors showed a pseudocapsule at the periphery of the lesion and four tumors grew around the tendon. On enhanced MRI examination, the myofibromas may exhibit peripheral enhancement, nodular enhancement, homogeneous or heterogeneous enhancement, and mild to marked enhancement, and some cases showed no enhancement [12, 15, 16]. The peripheral/rim-like enhancement occurred mostly in infants and young children [14, 15, 2224]. In our enhanced MRI studies, all 17 tumors appeared as a heterogeneous marked enhancement, without peripheral/rim-like enhancement. The signal characteristics of intraosseous lesions were similar to those of soft tissue lesions. However, there were also unusual imaging findings reported in the literature, Marret et al. [28] described a rare imaging finding of myofibroma that the lesion was disguised as humeral osteomyelitis on MRI.
Murphey et al. [14] and Salerno et al. [30] considered the different MRI signals of the myofibromas depending on the main pathological patterns of the tumors. Holzer et al. [15] suggested that the hypointensity on T2WI might be due to the high cellularity of the lesions. Naffaa et al. [12] considered that the extent of hyperintensity on T2WI indicated variable grades of cellularity, collagenization, and myxoid changes, and suggested that the pattern of enhancement on MRI does not correlate to any specific histopathology grade. Our pathological examinations revealed that tumor cells were interlaced with collagen fibers and fibrosis in all tumors. Correspondingly, on T2WI and FS T2WI, we found that the hyperintense area was interspersed with irregular strip or/and patchy hypointensities in all lesions. Interestingly, 5 of them showed a pseudocapsule consisting of peripheral collagen fibers on pathology which was exactly corresponding to the pseudocapsule at the tumor periphery on all MRI sequences. Therefore, our results demonstrated that the hypointense areas on all MRI sequences may be indicative of interlacing collagen fibers and fibrosis rather than calcification, in other words, the interlacing collagen fibers and fibrosis should be the dominant factors for these hypointensities.
This study had several limitations. First, this is a retrospective study, which means that there were no perfect imaging protocols, different MDCT and MRI equipments and techniques were used. Second, the relatively smaller sample size is another limitation. Third, owing to a lack of detailed clinical information in this group of cases, all cases were examined only by local imaging examinations but not by whole-body examinations, so the number of multifocal and generalized lesions may be underestimated. However, these problems are unavoidable due to the rarity of this type of tumor, and this should not have a significant impact on the radiological characteristics studied.

Conclusion

In conclusion, myofibromas are usually characterized by heterogeneous density or signal intensity, with moderate or marked enhancement. Our study is the first to describe that myofibroma could present a pseudocapsule at the periphery of the lesion and grow around the tendon, and the irregular strip or/and patchy hypointensities could be noted on all MRI sequences. Although these imaging characteristics of myofibromas are still nonspecific and the final diagnosis must be made by pathology, we believe that the results of this report may be helpful in the diagnosis of tumors and in differentiating them from other bone and soft tissue tumors on imaging.

Acknowledgments

Not applicable.
The study was approved by the ethics committee of the Daping Hospital of Army Medical University. The need for individual consent was waived by the committee.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer. 1981;48:1807–18.CrossRef Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer. 1981;48:1807–18.CrossRef
2.
Zurück zum Zitat Matthews MR, Cockerell CJ. An historic perspective of infantile myofibromatosis. Adv Dermatol. 2006;22:279–305.CrossRef Matthews MR, Cockerell CJ. An historic perspective of infantile myofibromatosis. Adv Dermatol. 2006;22:279–305.CrossRef
3.
Zurück zum Zitat Mentzel T, Dei Tos AF, Sapi Z, Kutzner H. Myopericytoma of skin and soft tissues: Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104–13.CrossRef Mentzel T, Dei Tos AF, Sapi Z, Kutzner H. Myopericytoma of skin and soft tissues: Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104–13.CrossRef
4.
Zurück zum Zitat Fletcher CD, Hogendoorn PC, Mertens F, Bridge J. WHO classification of tumors of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. Fletcher CD, Hogendoorn PC, Mertens F, Bridge J. WHO classification of tumors of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.
5.
Zurück zum Zitat Martignetti JA, Tian L, Li D, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92:1001–7.CrossRef Martignetti JA, Tian L, Li D, et al. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis. Am J Hum Genet. 2013;92:1001–7.CrossRef
6.
Zurück zum Zitat Lepelletier C, Al-Sarraj Y, Bodemer C, et al. Heterozygous PDGFRB mutation in a three-generation family with autosomal dominant infantile myofibromatosis. Acta Derm Venereol. 2017;97:858–9.CrossRef Lepelletier C, Al-Sarraj Y, Bodemer C, et al. Heterozygous PDGFRB mutation in a three-generation family with autosomal dominant infantile myofibromatosis. Acta Derm Venereol. 2017;97:858–9.CrossRef
7.
Zurück zum Zitat Oudijk L, den Bakker MA, Hop WC, et al. Solitary, multifocal and generalized myofibromas: Clinicopathological and immunohistochemical features of 114 cases. Histopathology. 2012;60:E1–11.CrossRef Oudijk L, den Bakker MA, Hop WC, et al. Solitary, multifocal and generalized myofibromas: Clinicopathological and immunohistochemical features of 114 cases. Histopathology. 2012;60:E1–11.CrossRef
8.
Zurück zum Zitat Stanford D, Rogers M. Dermatological presentations of infantile myofibromatosis: a review of 27 cases. Australas J Dermatol. 2000;41:156–61.CrossRef Stanford D, Rogers M. Dermatological presentations of infantile myofibromatosis: a review of 27 cases. Australas J Dermatol. 2000;41:156–61.CrossRef
9.
Zurück zum Zitat Mashiah J, Hadj-Rabia S, Dompmartin A, et al. Infantile myofibromatosis: a series of 28 cases. J Am Acad Dermatol. 2014;71:264–70.CrossRef Mashiah J, Hadj-Rabia S, Dompmartin A, et al. Infantile myofibromatosis: a series of 28 cases. J Am Acad Dermatol. 2014;71:264–70.CrossRef
10.
Zurück zum Zitat Wiswell TE, Davis J, Cunningham BE, Solenberger R, Thomas PJ. Infantile myofibromatosis: the most common fibrous tumor of infancy. J Pediatr Surg. 1988;23:314–8.CrossRef Wiswell TE, Davis J, Cunningham BE, Solenberger R, Thomas PJ. Infantile myofibromatosis: the most common fibrous tumor of infancy. J Pediatr Surg. 1988;23:314–8.CrossRef
11.
Zurück zum Zitat Merrell SC, Rahbar R, Alomari AI, et al. Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions. J Craniofac Surg. 2010;21:422–6.CrossRef Merrell SC, Rahbar R, Alomari AI, et al. Infantile myofibroma or lymphatic malformation: differential diagnosis of neonatal cystic cervicofacial lesions. J Craniofac Surg. 2010;21:422–6.CrossRef
12.
Zurück zum Zitat Naffaa L, Khalifeh I, Salman R, Itani M, Saab R, Al-Kutoubi A. Infantile myofibromatosis: review of imaging findings and emphasis on correlation between MRI and histopathological findings. Clin Imag. 2019;54:40–7.CrossRef Naffaa L, Khalifeh I, Salman R, Itani M, Saab R, Al-Kutoubi A. Infantile myofibromatosis: review of imaging findings and emphasis on correlation between MRI and histopathological findings. Clin Imag. 2019;54:40–7.CrossRef
13.
Zurück zum Zitat Wiswell TE, Sakas EL, Stephenson SR, Lesica JJ, Reddoch SR. Infantile myofibromatosis. Pediatrics. 1985;76:981–4.PubMed Wiswell TE, Sakas EL, Stephenson SR, Lesica JJ, Reddoch SR. Infantile myofibromatosis. Pediatrics. 1985;76:981–4.PubMed
14.
Zurück zum Zitat Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK, Miettinen M. From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation. RadioGraphics. 2009;29:2143–73.CrossRef Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK, Miettinen M. From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation. RadioGraphics. 2009;29:2143–73.CrossRef
15.
Zurück zum Zitat Holzer-Fruehwald L, Blaser S, Rossi A, Fruehwald-Pallamar J, Thurnher MM. Imaging findings in seven cases of congenital infantile myofibromatosis with cerebral, spinal, or head and neck involvement. Neuroradiology. 2012;54:1389–98.CrossRef Holzer-Fruehwald L, Blaser S, Rossi A, Fruehwald-Pallamar J, Thurnher MM. Imaging findings in seven cases of congenital infantile myofibromatosis with cerebral, spinal, or head and neck involvement. Neuroradiology. 2012;54:1389–98.CrossRef
16.
Zurück zum Zitat Lee SM, Ha DH, Kang H, Shin DE. Solitary myofibroma of the lumbar vertebra in young adult: A case report with 4-year follow-up of postoperative CT or MRI. Medicine (Baltimore). 2017;96:e8069.CrossRef Lee SM, Ha DH, Kang H, Shin DE. Solitary myofibroma of the lumbar vertebra in young adult: A case report with 4-year follow-up of postoperative CT or MRI. Medicine (Baltimore). 2017;96:e8069.CrossRef
17.
Zurück zum Zitat Tsuchie H, Bianchi G, Gambarotti M, Donati DM. Solitary intraosseous myofibroma of the ilium in an adult patient: a case report and literature review. J Orthop Sci. 2020;25:729–33.CrossRef Tsuchie H, Bianchi G, Gambarotti M, Donati DM. Solitary intraosseous myofibroma of the ilium in an adult patient: a case report and literature review. J Orthop Sci. 2020;25:729–33.CrossRef
18.
Zurück zum Zitat Wu W, Chen J, Cao X, Yang M, Zhu J, Zhao G. Solitary infantile myofibromatosis in the bones of the upper extremities: two rare cases and a review of the literature. Oncol Lett. 2013;6:1406–8.CrossRef Wu W, Chen J, Cao X, Yang M, Zhu J, Zhao G. Solitary infantile myofibromatosis in the bones of the upper extremities: two rare cases and a review of the literature. Oncol Lett. 2013;6:1406–8.CrossRef
19.
Zurück zum Zitat Soper JR, De Silva M. Infantile myofibromatosis: a radiological review. Pediatr Radiol. 1993;23:189–94.CrossRef Soper JR, De Silva M. Infantile myofibromatosis: a radiological review. Pediatr Radiol. 1993;23:189–94.CrossRef
20.
Zurück zum Zitat Allon I, Vered M, Buchner A, Dayan D. Central (intraosseous) myofibroma of the mandible: clinical, radiologic, and histopathologic features of a rare lesion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e45–53.CrossRef Allon I, Vered M, Buchner A, Dayan D. Central (intraosseous) myofibroma of the mandible: clinical, radiologic, and histopathologic features of a rare lesion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:e45–53.CrossRef
21.
Zurück zum Zitat Eich GF, Hoeffel JC, Tschappeler H, Gassner I, Willi UV. Fibrous tumours in children: imaging features of a heterogeneous group of disorders. Pediatr Radiol. 1998;28:500–9.CrossRef Eich GF, Hoeffel JC, Tschappeler H, Gassner I, Willi UV. Fibrous tumours in children: imaging features of a heterogeneous group of disorders. Pediatr Radiol. 1998;28:500–9.CrossRef
22.
Zurück zum Zitat Counsell SJ, DeVile C, Mercuri E, Allsop JM, Birch R, Muntoni F. Magnetic resonance imaging assessment of infantile myofibromatosis. Clin Radiol. 2002;57:67–70.CrossRef Counsell SJ, DeVile C, Mercuri E, Allsop JM, Birch R, Muntoni F. Magnetic resonance imaging assessment of infantile myofibromatosis. Clin Radiol. 2002;57:67–70.CrossRef
23.
Zurück zum Zitat Koujok K, Ruiz RE, Hernandez RJ. Myofibromatosis: imaging characteristics. Pediatr Radiol. 2005;35:374–80.CrossRef Koujok K, Ruiz RE, Hernandez RJ. Myofibromatosis: imaging characteristics. Pediatr Radiol. 2005;35:374–80.CrossRef
24.
Zurück zum Zitat Machan K, Bravo Bravo C, Martínez-León MI, Affumicato L. Infantile myofibromatosis. Study of a case using whole body ultrasound and MRI. Radiología. 2014;56:80–3.CrossRef Machan K, Bravo Bravo C, Martínez-León MI, Affumicato L. Infantile myofibromatosis. Study of a case using whole body ultrasound and MRI. Radiología. 2014;56:80–3.CrossRef
25.
Zurück zum Zitat Davies RS, Carty H, Pierro A. Infantile myofibromatosis-a review. Br J Radiol. 1994;67:619–23.CrossRef Davies RS, Carty H, Pierro A. Infantile myofibromatosis-a review. Br J Radiol. 1994;67:619–23.CrossRef
26.
Zurück zum Zitat Swaika S, Thomas B, Kapilamoorthy TR. Solitary infantile myofibroma of left ethmoid sinus with intracranial extension. Pediatr Neurol. 2016;57:107–8.CrossRef Swaika S, Thomas B, Kapilamoorthy TR. Solitary infantile myofibroma of left ethmoid sinus with intracranial extension. Pediatr Neurol. 2016;57:107–8.CrossRef
27.
Zurück zum Zitat Chen CL, Chang H. An unusual timing for symptomatic chest pain in an adult chest wall myofibroma: a case report. J Med Case Rep. 2014;8:210.CrossRef Chen CL, Chang H. An unusual timing for symptomatic chest pain in an adult chest wall myofibroma: a case report. J Med Case Rep. 2014;8:210.CrossRef
28.
Zurück zum Zitat Marret JC, Chauhan A, Hescock G, Warrier R, Stark MW. A rare disorder masquerading as osteomyelitis. Diagnosis: multicentric myofibromatosis. Clin Pediatr (Phila). 2015;54:806–8.CrossRef Marret JC, Chauhan A, Hescock G, Warrier R, Stark MW. A rare disorder masquerading as osteomyelitis. Diagnosis: multicentric myofibromatosis. Clin Pediatr (Phila). 2015;54:806–8.CrossRef
29.
Zurück zum Zitat Green MC, Dorfman HD, Villanueva-Siles E, et al. Aggressively recurrent infantile myofibroma of the axilla and shoulder girdle. Skelet Radiol. 2011;40:357–61.CrossRef Green MC, Dorfman HD, Villanueva-Siles E, et al. Aggressively recurrent infantile myofibroma of the axilla and shoulder girdle. Skelet Radiol. 2011;40:357–61.CrossRef
30.
Zurück zum Zitat Salerno S, Terranova MC, Rossello M, Piccione M, Ziino O, Re GL. Whole-body magnetic resonance imaging in the diagnosis and follow-up of multicentric infantile myofibromatosis: a case report. Mol Clin Oncol. 2017;6:579–82.CrossRef Salerno S, Terranova MC, Rossello M, Piccione M, Ziino O, Re GL. Whole-body magnetic resonance imaging in the diagnosis and follow-up of multicentric infantile myofibromatosis: a case report. Mol Clin Oncol. 2017;6:579–82.CrossRef
Metadaten
Titel
Myofibroma/myofibromatosis: MDCT and MR imaging findings in 24 patients with radiological-pathological correlation
verfasst von
Kun-ming Yi
Kang Chen
Qiang Ma
Lu Wang
Ran Li
Yi Wang
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Medical Imaging / Ausgabe 1/2020
Elektronische ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-020-00498-9

Weitere Artikel der Ausgabe 1/2020

BMC Medical Imaging 1/2020 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.